FREE CASE EVALUATION: 1-800-632-1404
Patients using Xarelto blood thinner are at the enhanced risk of brain hemorrhage and the danger assumes grievous propotions in the absence of any effective agent to reverse the drug effects. A Xarelto lawsuit filed in a Louisiana eastern district federal court claims that the plaintiff suffered from serious and life-threatening brain hemorrhage after he was treated with the drug. Manufactured by Bayer and marketed by Janssen, the blood thinner has been cited for causing serious internal bleeding complications.
According to the lawsuit, James J. Brien was prescribed Xarelto in April 2013 following diagnosis of non-valvular atrial fibrillation, a cardiac complication. He was hospitalized following brain hemorrhage in September 2014 and endured a paralysis attack. Though he was discharged after months of recovery and rehab process, the patient suffered from walking disability. The plaintiff took the blood thinner as directed to avert heart strokes, but he ended up in damage to his brain unaware of side effect hazards, his Xarelto attorney claims.
It is unsuspecting for the plaintiff to predict adverse events, such as internal bleeding, while he started taking the drug, as there was no such information by the manufacturer. He came to know about it only after research reports hinted at serious bleeding events and filed a Xarelto lawsuit seeking product liability and recovery of damages.
Xarelto Blood Thinner Hemorrhage Risks
In June 2014, a Xarelto lawsuit filed in a Florida court linked the blood thinner to fatal subdural hemorrhage condition. William Packard died of uncontrollable brain hemorrhage within six months of taking the drug to treat atrial fibrillation. His family has sought $10 million in economic and non-economic damages from the blood thinner manufacturers. It followed many similar claims blaming the medication for cerebral hemorrhage, intracranial bleeding, and gastrointestinal bleeding.
Stroke or rupture in blood vessels spills out the blood into the skull, tissues, and membranes. Patients experience intracranial pressure, irritation, inflammation, swelling, and development of hematoma. As a result the blood-oxygen supply to the brain was prevented and brain cells can die. Such type of cerebral hemorrhage has the potential to cause permanent brain damage and cognitive complications, such as vision loss, seizures, confusion, and coma.
Xarelto attorneys claim that the medication has the ability to “interrupt the intrinsic and extrinsic pathways of the blood coagulation cascade” for 24 hours and it has the potential to worsen patient conditions with excessive, life-threatening bleeding, as there is no medication at present to counter its anticougaltion properties. Due to the drug’s ability to “bind to plasma proteins tightly,” even dialysis proves to be futile to cleanse the body of the medication. In Germany, at least 72 people and 890 had died hemorrhage in 2013 linked to Xarelto internal bleeding.
In 2013, the American Heart Association warned of three-fold greater internal bleeding risk in patients using the blood thinner. The hazard goes up for patients with Acute Coronary Syndrome. Following reports of high-bleeding cost vis-à-vis the drug efficacy, the FDA refused to allow Xarelto as a mode of treatment for those suffering from Acute Coronary Syndrome.
In December 2013, the Journal of the American College of Cardiology cited research findings highlighting that 74% of Xarelto internal bleeding events are intracerebral hemorrhage type.
Possible Xarelto Brain Hemorrhage Injuries
- Wrongful death
- Damage to brain
- Swelling and inflammation of brain
- Intracranial hematoma in brain
- Seizures
- Coma
- Loss of vision
- Intracranial pressure
Xarelto Lawsuit
The FDA approved Xarelto blood thinner in 2011 to treat potential risk of blood clotting that can cause heart attack, pulmonary embolism, thrombolic events, and stroke in patients. However, research studies have found that the drug does not offer any significant advantage over other and existing anticoagulants. Additionally, it poses higher risk of frequent brain, stomach, and intestine bleeding that can be life threatening. Xarelto attorneys claim that overpromotion of the drug as superior and suppression of side effects by manufacturers misled their clients to use the blood thinner and suffer from fatal complications.
About 30 Xarelto lawsuits have been filed in 14 states citing “negligence, concealing of information, misrepresentation, and false advertisement” by the manufacturer. If you have a potential claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with an Xarelto attorney.
Contact a Xarelto Injury Lawyer Today.
If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.
For a Free Case Evaluation:
TOLL FREE: 1-800-632-1404
EMAIL: click here
FILL OUT THIS FORM:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.
2 Replies to “Xarelto Lawsuit Filed Over Brain Hemorrhage”